BGM Stock Analysis: Buy, Sell, or Hold?
BGM - BGM Group Ltd. Class A Ordinary Shares
$0.29
0.00 (0.71%)
β²
5d:
-12.98%
30d:
-3.75%
90d:
-2.06%
WAIT
LOW Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Mar 10, 2026
0d
Get Alerted When BGM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: BGM is down 13.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: BGM is down 13.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BGM is currently trading at $0.28, which is considered fair relative to its 30-day fair value range of $0.27 to $0.30.
Technical Outlook: Technically, BGM is in a downtrend. Immediate support is located at $0.23, while resistance sits at $0.33.
Market Sentiment: BGM scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BGM is in a downtrend. Immediate support is located at $0.23, while resistance sits at $0.33.
Market Sentiment: BGM scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.27 -
$0.30
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
85.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- WARNING: Composite score 45/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.27 -
$0.30
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.23
Resistance Level
$0.33
Current Trend
Downtrend
Technical data as of
Sep 4, 2026
Fundamental Context
Revenue Growth (YoY)
69.8%
Profit Margin
-44.2%
Share & Embed Analysis
Last updated: September 07, 2026 2:07 AM ET
Data refreshes hourly during market hours. Next update: 3:07 AM
Data refreshes hourly during market hours. Next update: 3:07 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BGM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I⦠|
STRONG BUY
25 analysts |
$212 | 61 BUY |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 77 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 54 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$96 | 41 HOLD |
|
UTHR
United Therapeutics Corp⦠|
STRONG BUY
15 analysts |
$664 | 44 HOLD |